Litton Mark James
CIK 0001604834
President and CEODirector
Filings
16
Latest Apr 13, 2026
Issuers covered
1
Showing
16 of 16
Page 1
Track record
Realized signed returns on open-market buys and sales
No scored trades yet for Litton Mark James. Track record appears once open-market purchases or sales reach the +30 day horizon.
Issuers
Companies where Litton Mark James has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| ATHA | Athira Pharma, Inc. | 16 | Apr 13, 2026 |
All filings
16 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|